Document is current
Any future updates will be listed below
-
Authors
Rezapour, Jasmin
Bowd, Christopher
Dohleman, Jade
Belghith, Akram
Proudfoot, James A.
Christopher, Mark
Hyman, Leslie
Jonas, Jost B.
Fazio, Massimo A.
Weinreb, Robert N.
Zangwill, Linda M.
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (RE4155/1-1)
Deutsche Ophthalmologische Gesellschaft
National Eye Institute (K99 EY030942, R01EY026574, R01EY029058, R01EY026574)
Research to Prevent Blindness (Unrestricted Grant)
BrightFocus Foundation (2017122)
- License Information
-
More Information
Article History
Received: 19 October 2020
Accepted: 5 April 2021
First Online: 23 April 2021
Competing interests
: JR: No competing interests CB: No competing interests JD: No competing interests AB: No competing interests JAP: No competing interests MC: No competing interests LH: No competing interests JBJ: No competing interests MAF: No competing interests LMZ: Research support and/or equipment from: Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Topcon, Inc. RNW: Consultant: Aerie Pharmaceuticals, Allergan, Eyenovia, Implantdata; Unity. Financial Support: Heidelberg Engineering, Carl Zeiss Meditec, Konan, Optovue, Genentech, Optos, Centervue, Bausch&Lomb; Patent: Toromedes, Carl Zeiss Meditec.
